MedTrace Logo

Predicting Difficult Airway in Children

NCT03641157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 108

Last updated 2018-08-21

No results posted yet for this study

Summary

Background: Obtaining airway security holds the utmost importance in anesthesia. Specific predictive tests or findings for difficult airway are not defined for various pediatric age groups. Anthropometric measurements are defined parallel to percentile curves in different age groups.

Aim: The aim of this study is to find out the value of body mass index and anthropometric measurements in prediction of difficult laryngoscopy in children by comparing to direct laryngoscopic evaluation of Cormack-Lehane test.

Methods: Following institutional ethics committee approval and informed consent of parents of 108 patients (ages 0-3years), undergoing elective surgery were included in this study. Weight, height, body mass index and head circumference of the patients were measured and percentiles were recorded, prior to induction.

Following standard anesthesia induction with thiopental all patients received 0,6 mg.kg-1 rocuronium intravenously. After sufficient time for neuromuscular relaxation laryngoscopy performed and Cormack-Lehane scores recorded. All recorded parameters were compared with Cormack-Lehane scores.

Conditions

  • Difficult Intubation
  • Pediatrics

Interventions

OTHER

Easy Intubation

Sponsors & Collaborators

  • Tepecik Training and Research Hospital

    lead OTHER

Principal Investigators

  • PERVIN BOZKURT, Prof · Tepecik Education and Research Hospital

Eligibility

Min Age
1 Month
Max Age
36 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-11
Primary Completion
2016-07-11
Completion
2016-07-11

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03641157 on ClinicalTrials.gov